(Q44600541)

4 December 2017

Azithromycin for the treatment of pertussis (English)

1 reference

4 December 2017

0 references

Michael E. Pichichero

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14515842

15 March 2024

William J. Hoeger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14515842

15 March 2024

Janet R. Casey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14515842

15 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14515842

15 March 2024

publication date

1 September 2003

1 reference

Pediatric Infectious Disease Journal

4 December 2017

1 reference

4 December 2017

22

1 reference

4 December 2017

9

1 reference

4 December 2017

847-849

1 reference

Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin.

4 December 2017

1

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000083884.75901.1E

Short-term treatment of pertussis with azithromycin in infants and young children.

15 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000083884.75901.1E

Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial

15 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000083884.75901.1E

Microbiological and serological diagnosis of pertussis

15 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000083884.75901.1E

Specific identification of Bordetella pertussis by the polymerase chain reaction

15 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000083884.75901.1E

Antimicrobial treatment of pertussis

15 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000083884.75901.1E

The Whooping Cough Syndrome: A Continuing Pediatric Problem

15 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000083884.75901.1E

Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects.

15 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000083884.75901.1E

Seven Days of Erythromycin Estolate Is as Effective as Fourteen Days for the Treatment of Bordetella pertussis Infections

15 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000083884.75901.1E

Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis

15 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000083884.75901.1E

15 March 2024

Identifiers

1 reference

4 December 2017

1 reference